Warning, recall, alert: Unsanitary lab conditions raise US FDA alarm

By Flora Southey

- Last updated on GMT

(Image: Getty/Murat Göçmen)
(Image: Getty/Murat Göçmen)
An inspection of Ranier’s Compounding Laboratory has revealed poor sterile production practices, says the US FDA.

The US Food and Drug Administration (FDA) has alerted healthcare professionals, patients, veterinarians and animal owners against using and administering certain drug products from Ranier’s Compounding Laboratory in Jeannette, Pennsylvania.

According to the Agency, inspectors observed insanitary conditions, including poor sterile production practices, during a recent visit to the laboratory.

“Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death,” ​warned the FDA.

The alert follows an FDA warning letter​ issued to the firm in March 2017, and a subsequent request that Rainer’s Compounding recall all drug products intended to be sterile. The Agency also recommended the firm cease sterile operations until it addressed the concerns.

According to the FDA, “On June 7, 2018, Ranier’s Pharmacy informed FDA that it agreed to voluntarily recall and cease sterile operations. However, the company has failed to comply with its commitment.”

Ranier’s Compounding Laboratory – which is associated with Ranier’s Pharmacy and Ranier’s RX Laboratory – did not respond to a request to comment ahead of publication.

Related news

Show more

Related products

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

The Complete Guide to eRegulatory and eSource

The Complete Guide to eRegulatory and eSource

Content provided by Florence Healthcare | 01-Apr-2023 | Insight Guide

Shifting to eRegulatory and eSource workflows is a requirement for clinical trial sites to continue to scale and grow their studies. This guide is designed...

Follow us


View more